Benchmark Holdings

行业

渔业与水产养殖, 种子与遗传育种

主题

虾/鱼遗传育种与水产养殖技术

角色

未分类

为何属于生物经济

Benchmark Holdings 是水产养殖生物技术公司，为水产养殖提供先进的营养和健康方案。

尚未被列为已评级方案的供应商。

• 2025-08 最新状态: 公司名称由Benchmark Holdings plc变更为Benchmark Holdings Limited，并于2025年8月从AIM和Euronext Growth奥斯陆退市。 ↗ ↗ ↗
• 2025-07-25 Result of Tender Offer - Replacement | Company Announcement | Investegate
  Benchmark Holdings plc conducted a tender offer, purchasing 127,720,171 ordinary shares (all tendered), cancelling them and returning about £31.9 million to shareholders. After the cancellation, total outstanding shares will be 614,702,942 with voting rights …
• 2025-08-18 Sheffield tech firm quits London Stock Exchange after £32m move
  Benchmark Holdings plc, a Sheffield biotechnology firm, has delisted from the London Stock Exchange and Euronext Growth Oslo to re-register as a private company, returning around £95m to shareholders after previously selling its genetics business. The move, …
• 2025-07-25 Benchmark Holdings will pay £31.9m to stakeholders in buy-back offer
  Benchmark Holdings is moving from a public listing to a private company after a buy-back of up to 226.9m shares; it bought back 127.7m shares for £31.9m, with those shares to be cancelled, increasing the combined stake of its three biggest holders (Ferd AS, …
• 2025-06-12 Genetics operation sale nets £76m profit for biotech business | TheBusinessDesk.com
  Benchmark Holdings, a Sheffield-based aquaculture biotechnology company, reported a £76m group profit for the six months to 31 March 2025, driven by a £90.9m gain from selling its Genetics operation and ongoing cost-cutting after de-listing from AIM and …
• 2025-05-23 Benchmark planning a £56.7m share buy-back and exit from stock markets
  Benchmark Holdings plans to de-list from AIM and Oslo, buy back about £56.7m of shares and issue a special dividend as it re-registers as a private company after selling its genetics division for £230m to Novo Holdings, leaving two remaining segments (Health …
• 2025-05-23 Benchmark Holdings to delist following £260 million sale of Genetics arm | Salmon Business
  Benchmark Holdings is planning to delist from AIM and Euronext Growth after selling its aquaculture genetics division to Novo Holdings for £260 million, and will convert to a private company with plans to return proceeds to shareholders. The move follows a …

股权与投资方 1

同类企业

AquaGen · INVE Aquaculture · Landcatch Natural Selection · STIM · Aqua Pharma Group · PatoGen AS · GenoMar Genetics · PHARMAQ Analytiq AS